STING/Type I Interferon Pathway Activation Confers Multimodal Therapeutic Benefits in Osteomyelitis
STING/type I interferon signaling counteracts osteomyelitis through coordinated control of pain, bone destruction, and abscess formation. It inhibits pathogen‐induced nociceptor activation, restrains osteoclast‐mediated bone resorption, and suppresses IL‐1β‐driven neutrophil recruitment.
Yang Chen +19 more
wiley +1 more source
Neural Expression of IL-16 Mediates Neuropathic Pain after Sciatic Injury in Mice. [PDF]
Coro-Martín A +6 more
europepmc +1 more source
Effects of phytocannabinoids, synthetic and semi-synthetic cannabinoids on microglia and astrocytes: Review of neuroinflammatory mechanisms. [PDF]
Brambilla G +4 more
europepmc +1 more source
Aripiprazole modulates splenic microbiota and immune response elicited by single prolonged stress in rats. [PDF]
Vargovic P +4 more
europepmc +1 more source
Systemic immune-inflammatory disturbance and multiorgan dysfunction in patients with sepsis-associated acute-on-chronic liver failure. [PDF]
Liu J, Jiang L, Liu Y, Chang Y.
europepmc +1 more source
Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade. [PDF]
Honap S +6 more
europepmc +1 more source
Functional Heterogeneity of Immune Cell Subpopulations in Atherosclerosis: From Basic Mechanisms to Precision Therapy. [PDF]
Li M, Bian C, Li B.
europepmc +1 more source

